• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人凝血因子 VIIa 和组织因子的膜结合和复合物形成的动力学观点。

Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.

机构信息

Beckman Institute for Advanced Science and Technology, University of Illinois, Urbana, IL, USA.

出版信息

J Thromb Haemost. 2010 May;8(5):1044-53. doi: 10.1111/j.1538-7836.2010.03826.x. Epub 2010 Feb 24.

DOI:10.1111/j.1538-7836.2010.03826.x
PMID:20180816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2890040/
Abstract

SUMMARY BACKGROUND

The molecular mechanism of enhancement of the enzymatic activity of factor VIIa by tissue factor (TF) is not fully understood, primarily because of the lack of atomic models for the membrane-bound form of the TF-FVIIa complex.

OBJECTIVES

To construct the first membrane-bound model of the TF-FVIIa complex, and to investigate the dynamics of the complex in solution and on the surface of anionic membranes by using large-scale molecular dynamics (MD) simulations in full atomic detail.

METHODS

Membrane-bound models of the TF-FVIIa complex and the individual factors were constructed and subjected to MD simulations, in order to characterize protein-protein and protein-lipid interactions, and to investigate the dynamics of TF and FVIIa.

RESULTS

The MD trajectories reveal that isolated FVIIa undergoes large structural fluctuation, primarily due to the hinge motions between its domains, whereas soluble TF (sTF) is structurally stable. Upon complex formation, sTF restricts the motion of FVIIa significantly. The results also show that, in the membrane-bound form, sTF directly interacts with the lipid headgroups, even in the absence of FVIIa.

CONCLUSION

The first atomic models of membrane-bound sTF-FVIIa, FVIIa and sTF are presented, revealing that sTF forms direct contacts with the lipids, both in the isolated form and in complex with FVIIa. The main effect of sTF binding to FVIIa is spatial stabilization of the catalytic site of FVIIa, which ensures optimal interaction with the substrate, FX.

摘要

摘要背景

组织因子(TF)增强因子 VIIa 的酶活性的分子机制尚未完全了解,主要是因为缺乏膜结合形式的 TF-FVIIa 复合物的原子模型。

目的

构建 TF-FVIIa 复合物的第一个膜结合模型,并通过全原子细节的大规模分子动力学(MD)模拟研究复合物在溶液中和阴离子膜表面的动力学。

方法

构建 TF-FVIIa 复合物和各个因子的膜结合模型,并进行 MD 模拟,以表征蛋白-蛋白和蛋白-脂质相互作用,并研究 TF 和 FVIIa 的动力学。

结果

MD 轨迹表明,孤立的 FVIIa 会发生大的结构波动,主要是由于其结构域之间的铰链运动,而可溶性 TF(sTF)结构稳定。复合物形成后,sTF 显著限制了 FVIIa 的运动。结果还表明,在膜结合形式下,sTF 直接与脂质头部基团相互作用,即使在没有 FVIIa 的情况下也是如此。

结论

提出了第一个膜结合形式的 sTF-FVIIa、FVIIa 和 sTF 的原子模型,揭示了 sTF 与脂质形成直接接触,无论是在游离形式还是与 FVIIa 复合物中。sTF 与 FVIIa 结合的主要作用是空间稳定 FVIIa 的催化位点,从而确保与底物 FX 的最佳相互作用。

相似文献

1
Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.人凝血因子 VIIa 和组织因子的膜结合和复合物形成的动力学观点。
J Thromb Haemost. 2010 May;8(5):1044-53. doi: 10.1111/j.1538-7836.2010.03826.x. Epub 2010 Feb 24.
2
Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.可溶性组织因子与全长组织因子对凝血因子VIIa的不同作用所涉及的分子决定因素。
Phys Chem Chem Phys. 2017 Aug 23;19(33):22230-22242. doi: 10.1039/c7cp02179h.
3
Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.七因子在文昌鱼中通过组织因子的别构激活的进化保守性。
J Thromb Haemost. 2018 Apr;16(4):734-748. doi: 10.1111/jth.13968. Epub 2018 Mar 12.
4
Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.凝血因子VIIa和组织因子的膜相互作用区域的作用。凝血因子VIIa的γ-羧基谷氨酸(Gla)结构域对于与组织因子的结合并非必需,但对凝血因子X的激活很重要。
J Biol Chem. 1994 Mar 18;269(11):8007-13.
5
Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X.因子VIIa/组织因子与因子X之间三元复合物的膜结合模型
Blood Adv. 2025 Feb 25;9(4):729-740. doi: 10.1182/bloodadvances.2024014845.
6
An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein docking and molecular dynamics refinement study.人外源性血液凝固复合物(sTF-VIIa-Xa)的全原子溶液平衡模型:蛋白质-蛋白质对接与分子动力学优化研究
J Thromb Haemost. 2003 Dec;1(12):2577-88. doi: 10.1111/j.1538-7836.2003.00421.x.
7
Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.以其人之道还治其人之身:可溶性非组织因子依赖的凝血因子VIIa的设计与特性
J Biol Chem. 2020 Jan 10;295(2):517-528. doi: 10.1074/jbc.RA119.009183. Epub 2019 Dec 4.
8
Structural modulation of factor VIIa by full-length tissue factor (TF): implication of novel interactions between EGF2 domain and TF.全长组织因子(TF)对因子 VIIa 的结构调节:EGF2 结构域与 TF 之间新的相互作用的意义。
J Biomol Struct Dyn. 2018 Feb;36(3):621-633. doi: 10.1080/07391102.2017.1289125. Epub 2017 Feb 17.
9
The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.凝血因子IX和凝血因子X中的N端表皮生长因子样结构域是与组织因子结合的重要识别基序。
J Biol Chem. 2002 Feb 1;277(5):3622-31. doi: 10.1074/jbc.M111202200. Epub 2001 Nov 26.
10
Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.凝血因子VIIa与组织因子复合物的过渡态分析:提示一种序列性结构域结合途径。
Biochem Biophys Res Commun. 2005 Feb 18;327(3):789-93. doi: 10.1016/j.bbrc.2004.12.058.

引用本文的文献

1
Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism.组织因子/因子VIIa复合物与X因子模拟物的冷冻电镜结构揭示了一种新型变构机制。
Blood. 2025 Aug 14. doi: 10.1182/blood.2025029430.
2
Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X.因子VIIa/组织因子与因子X之间三元复合物的膜结合模型
Blood Adv. 2025 Feb 25;9(4):729-740. doi: 10.1182/bloodadvances.2024014845.
3
A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders.

本文引用的文献

1
All-atom empirical potential for molecular modeling and dynamics studies of proteins.蛋白质分子建模和动力学研究的全原子经验势。
J Phys Chem B. 1998 Apr 30;102(18):3586-616. doi: 10.1021/jp973084f.
2
Protein-membrane interactions: blood clotting on nanoscale bilayers.蛋白质-膜相互作用:纳米级双分子层上的血液凝固
J Thromb Haemost. 2009 Jul;7 Suppl 1(Suppl 1):169-72. doi: 10.1111/j.1538-7836.2009.03390.x.
3
Blood clotting reactions on nanoscale phospholipid bilayers.纳米级磷脂双分子层上的血液凝固反应。
双特异性抗体方法可用于潜在的遗传性出血性疾病的预防性治疗。
Nat Cardiovasc Res. 2024 Feb;3(2):166-185. doi: 10.1038/s44161-023-00418-4. Epub 2024 Feb 8.
4
Authors' reply to the Letter to the Editor: Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer.作者回复给编辑的信:组织因子及其在胰腺癌相关血栓栓塞症中的促凝活性。
Cancer Sci. 2022 May;113(5):1888-1890. doi: 10.1111/cas.15324. Epub 2022 Mar 24.
5
Stoichiometric analysis reveals a unique phosphatidylserine binding site in coagulation factor X.化学计量分析揭示凝血因子 X 中存在独特的磷脂酰丝氨酸结合位点。
J Thromb Haemost. 2022 Mar;20(3):600-604. doi: 10.1111/jth.15620. Epub 2021 Dec 17.
6
Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.通过联合实验和计算方法揭示凝血因子的膜结合模型。
Thromb Haemost. 2021 Sep;121(9):1122-1137. doi: 10.1055/s-0040-1722187. Epub 2021 Jul 2.
7
Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization.凝血因子VII的新型突变(卡梅尔突变):鉴定与特征分析
Res Pract Thromb Haemost. 2021 Feb 25;5(4):e12407. doi: 10.1002/rth2.12407. eCollection 2021 May.
8
Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain.原子模拟阐明了凝血因子 VII 酶原的构象可塑性-刚性轴:N 端截短的因子 VIIa 蛋白酶结构域。
Biomolecules. 2021 Apr 8;11(4):549. doi: 10.3390/biom11040549.
9
How the tissue factor-VIIa complex keeps two substrates in the loop.组织因子 - VIIa 复合物如何使两种底物保持在循环中。
J Thromb Haemost. 2021 Jan;19(1):52-54. doi: 10.1111/jth.15148.
10
The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.成纤维细胞表面表达的组织因子促凝活性可被组织因子阴性细胞外囊泡所增强。
PLoS One. 2020 Oct 8;15(10):e0240189. doi: 10.1371/journal.pone.0240189. eCollection 2020.
Thromb Res. 2008;122 Suppl 1(Suppl 1):S23-6. doi: 10.1016/S0049-3848(08)70014-8.
4
Distinct structural and adhesive roles of Ca2+ in membrane binding of blood coagulation factors.钙离子在凝血因子膜结合中的独特结构和黏附作用。
Structure. 2008 Jan;16(1):72-81. doi: 10.1016/j.str.2007.10.021.
5
Tissue factor around dermal vessels has bound factor VII in the absence of injury.在未受伤的情况下,真皮血管周围的组织因子已结合了凝血因子VII。
J Thromb Haemost. 2007 Jul;5(7):1403-8. doi: 10.1111/j.1538-7836.2007.02576.x. Epub 2007 Apr 9.
6
A combined structural dynamics approach identifies a putative switch in factor VIIa employed by tissue factor to initiate blood coagulation.一种联合结构动力学方法确定了组织因子用于启动血液凝固的凝血因子VIIa中的一个假定开关。
Protein Sci. 2007 Apr;16(4):671-82. doi: 10.1110/ps.062504907.
7
Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X.鉴定组织因子上与因子X的第一个表皮生长因子样结构域相互作用的一个碱性区域。
Biochemistry. 2007 Mar 20;46(11):3193-9. doi: 10.1021/bi6025193. Epub 2007 Feb 27.
8
Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum.参与大分子识别与抑制的新型凝血因子Xa外部位点的分子间相互作用及表征:人无γ-羧基谷氨酸结构域凝血因子Xa与吸血线虫犬钩口线虫抗凝蛋白NAPc2复合物的晶体结构
J Mol Biol. 2007 Feb 16;366(2):602-10. doi: 10.1016/j.jmb.2006.11.040. Epub 2006 Nov 14.
9
What causes the enhancement of activity of factor VIIa by tissue factor?组织因子是如何导致凝血因子VIIa活性增强的?
J Thromb Haemost. 2006 Dec;4(12):2726-9. doi: 10.1111/j.1538-7836.2006.02222.x. Epub 2006 Sep 21.
10
Phosphatidic acid- and phosphatidylserine-binding proteins.磷脂酸和磷脂酰丝氨酸结合蛋白。
Biochim Biophys Acta. 2006 Aug;1761(8):913-26. doi: 10.1016/j.bbalip.2006.03.006. Epub 2006 Apr 3.